Temat: disease stage - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Differences in breast cancer incidence and stage distribution between urban and rural female population in Podlaskie voivodship, Poland in years 2001-2002
Autorzy:: Krzyzak, M
Maslach, D.
Juczewska, M.
Lasota, W.
Rabczenko, D.
Marcinkowski, J.T.
Szpak, A.
Powiązania:: https://bibliotekanauki.pl/articles/50013.pdf
Data publikacji:: 2010
Wydawca:: Instytut Medycyny Wsi
Tematy:: Polska
Podlasie voivodship
rural population
urban population
woman
breast cancer
human disease
distribution
differentiation
incidence
disease stage
Population Screening Programme
monitoring
diagnosis
Źródło:: Annals of Agricultural and Environmental Medicine; 2010, 17, 1; 159-162
1232-1966
Pojawia się w:: Annals of Agricultural and Environmental Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Assessment of the incidence rate of end-stage renal disease in patients with and without diabetes in Poland
Autorzy:: Wierzba, W.
Karnafel, W.
Tyszko, P.
Kanecki, K.
Śliwczyński, A.
Powiązania:: https://bibliotekanauki.pl/articles/2081907.pdf
Data publikacji:: 2018
Wydawca:: Instytut Medycyny Wsi
Tematy:: diabetes mellitus
end-stage renal disease
incidence rate
Opis:: Introduction. Several studies have suggested, that diabetes is very important factor of the risk of the chronic a renal disease. The paper aims to present a retrospective analysis of incidence of end-stage renal disease in subgroups of patients with and without diabetes in Poland. Material and methods. For assessing this problem an electronic search was performed using Polish National Health Fund data base from 01.01.2011 until 31.12.2013 in general population and from 01.01.2012 until 31.12.2012 in 2 populations: with diabetes and without diabetes mellitus. Results. The 43.70 % patients with end-stage renal disease was diabetic. The incidence rate in 2012 was: 292.48 ± 90.97 diabetic men / 100,000 diabetic population; 203.10 ± 90.97 diabetic women / 100,000 diabetic population; 23.44 ± 6.34 non-diabetic men / 100,000 non-diabetic population; 17.88 ± 6.33 non-diabetic women / 100,000 non-diabetic population. Conclusions. The incidence rate of end-stage renal failure in diabetics was multiple times higher than the incidence rate in non-diabetics. The incidence rate of new ESRD cases in Poland estimated to be 36.17 per 100,000 of general populations in 2011, 35.28% in 2012 and 30.46 per 100,000 of general populations in 2013. In 2012, the incidence rate of new ESRD cases in male diabetics was 292.48 ± 90.97 per 100,000 of diabetes men population, and in women diabetics 203.10 ± 66.06 per 100,000 of diabetes women population. In the same 2012 year, the incidence of new ESRD cases in men non-diabetics was 3.44 ± 6.34 per 100,000 of non-diabetes, and in women non-diabetes 17.58 ± 6.33 per 100,000 of non-diabetes women population.
Źródło:: Annals of Agricultural and Environmental Medicine; 2018, 25, 3; 568-571
1232-1966
Pojawia się w:: Annals of Agricultural and Environmental Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Long-time survival of a female with primary amyloidosis treated by peritoneal dialysis
Autorzy:: Grzebalska, Agnieszka M.
Sak, Jarosław
Prystupa, Andrzej
Książek, Andrzej
Powiązania:: https://bibliotekanauki.pl/articles/972730.pdf
Data publikacji:: 2017
Wydawca:: Instytut Medycyny Wsi
Tematy:: kidney failure
peritoneal dialysis
end-stage renal disease
Amyloidosis
Opis:: Introduction. Amyloidosis, both primary and secondary, is a systemic disease characterized by extracellular deposition of fibrillar protein in vital organs, leading to their injury and even insufficiency. It results in a poor diagnosis, especially for patients with primary amyloidosis. Kidney involvement is typical and usually manifests by proteinuria, mainly nephrotic range, leading to end-stage renal disease (ESRD). Patients with ESRD need renal replacement therapy (RRT). Some data claim that better results and longer patient, survival are observed in peritoneal dialysed rather than in haemodialysed patients. Case report. The case is described of 19-year-old Caucasian woman with primary amyloidosis. Inherited primary amyloidosis with abnormal apolipoprotein A-I was established. The patient was successfully treated with peritoneal dialysis for 87 months. After this period, she was transferred for haemodialysis. Such a long survival time on peritoneal dialysis (PD) in a patient with primary amyloidosis has not been found. It is believed that the lowering of immunoglobulin levels in blood and normalization of total protein in serum effectively removed, through dialysate, the pathological polyclonal proteins. This effect probably also sustained cardio-circulatory sufficiency of the patient and significantly prolonged her survival. Conclusion. Peritoneal dialysis is an effective and recommended method of treatment in patients suffering from primary amyloidosis. Peritoneal dialysis should be the first choice therapy in ESRD patient; contrary to haemodialysis, peritoneal dialysis removes pathological proteins and allows the avoidance of intra-dialytic hypotension.
Źródło:: Journal of Pre-Clinical and Clinical Research; 2017, 11, 1; 22-24
1898-2395
Pojawia się w:: Journal of Pre-Clinical and Clinical Research
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "disease stage" wg kryterium: Temat

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język